| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | Mulligan Margaret Jean | EVP, CFO | Nov 08, 2010 | Option Exercise | $26.12 | 47,644 | 1,244,461 | 83,014 | Nov 10, 2010, 05:46 PM |
Menu